Infectious Disease In-Vitro Diagnostics Market Size, Share, and Trends 2024 to 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Infectious Disease in-Vitro Diagnostics Market 

5.1. COVID-19 Landscape: Infectious Disease in-Vitro Diagnostics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Infectious Disease in-Vitro Diagnostics Market, By Product

8.1. Infectious Disease in-Vitro Diagnostics Market, by Product, 2023-2032

8.1.1 Instruments

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Reagents

8.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Infectious Disease in-Vitro Diagnostics Market, By Technology

9.1. Infectious Disease in-Vitro Diagnostics Market, by Technology, 2023-2032

9.1.1. Immunoassay

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Molecular Diagnostics

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Microbiology

9.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Infectious Disease in-Vitro Diagnostics Market, By Test Location 

10.1. Infectious Disease in-Vitro Diagnostics Market, by Test Location, 2023-2032

10.1.1. Point of Care

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Central Laboratories

10.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Infectious Disease in-Vitro Diagnostics Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product (2020-2032)

11.1.2. Market Revenue and Forecast, by Technology (2020-2032)

11.1.3. Market Revenue and Forecast, by Test Location (2020-2032)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.1.4.2. Market Revenue and Forecast, by Technology (2020-2032)

11.1.4.3. Market Revenue and Forecast, by Test Location (2020-2032)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.1.5.2. Market Revenue and Forecast, by Technology (2020-2032)

11.1.5.3. Market Revenue and Forecast, by Test Location (2020-2032)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product (2020-2032)

11.2.2. Market Revenue and Forecast, by Technology (2020-2032)

11.2.3. Market Revenue and Forecast, by Test Location (2020-2032)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.2.4.2. Market Revenue and Forecast, by Technology (2020-2032)

11.2.4.3. Market Revenue and Forecast, by Test Location (2020-2032)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.2.5.2. Market Revenue and Forecast, by Technology (2020-2032)

11.2.5.3. Market Revenue and Forecast, by Test Location (2020-2032)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product (2020-2032)

11.2.6.2. Market Revenue and Forecast, by Technology (2020-2032)

11.2.6.3. Market Revenue and Forecast, by Test Location (2020-2032)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product (2020-2032)

11.2.7.2. Market Revenue and Forecast, by Technology (2020-2032)

11.2.7.3. Market Revenue and Forecast, by Test Location (2020-2032)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product (2020-2032)

11.3.2. Market Revenue and Forecast, by Technology (2020-2032)

11.3.3. Market Revenue and Forecast, by Test Location (2020-2032)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.3.4.2. Market Revenue and Forecast, by Technology (2020-2032)

11.3.4.3. Market Revenue and Forecast, by Test Location (2020-2032)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.3.5.2. Market Revenue and Forecast, by Technology (2020-2032)

11.3.5.3. Market Revenue and Forecast, by Test Location (2020-2032)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product (2020-2032)

11.3.6.2. Market Revenue and Forecast, by Technology (2020-2032)

11.3.6.3. Market Revenue and Forecast, by Test Location (2020-2032)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product (2020-2032)

11.3.7.2. Market Revenue and Forecast, by Technology (2020-2032)

11.3.7.3. Market Revenue and Forecast, by Test Location (2020-2032)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.4.2. Market Revenue and Forecast, by Technology (2020-2032)

11.4.3. Market Revenue and Forecast, by Test Location (2020-2032)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.4.4.2. Market Revenue and Forecast, by Technology (2020-2032)

11.4.4.3. Market Revenue and Forecast, by Test Location (2020-2032)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.4.5.2. Market Revenue and Forecast, by Technology (2020-2032)

11.4.5.3. Market Revenue and Forecast, by Test Location (2020-2032)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product (2020-2032)

11.4.6.2. Market Revenue and Forecast, by Technology (2020-2032)

11.4.6.3. Market Revenue and Forecast, by Test Location (2020-2032)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product (2020-2032)

11.4.7.2. Market Revenue and Forecast, by Technology (2020-2032)

11.4.7.3. Market Revenue and Forecast, by Test Location (2020-2032)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.5.2. Market Revenue and Forecast, by Technology (2020-2032)

11.5.3. Market Revenue and Forecast, by Test Location (2020-2032)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.5.4.2. Market Revenue and Forecast, by Technology (2020-2032)

11.5.4.3. Market Revenue and Forecast, by Test Location (2020-2032)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.5.5.2. Market Revenue and Forecast, by Technology (2020-2032)

11.5.5.3. Market Revenue and Forecast, by Test Location (2020-2032)

Chapter 12. Company Profiles

12.1. QIAGEN

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. BD

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. BioMérieux SA

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. F. Hoffmann-La Roche, Ltd.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Hologic, Inc. (Gen Probe)

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Abbott

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Quidel Corporation

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Siemens Healthineers AG

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Bio-Rad Laboratories, Inc.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Danaher Corporation

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms